$5.5 million for cellvie
Event date: 06.02.2023
Cellvie is developing medicines from cells, leveraging the therapeutic potential of mitochondria, commonly known as the powerhouses of the cell. The fresh capital will be employed to accelerate the development of the company’s technology platform, strengthen the team, and further establish mitochondria manufacturing.